ZOMDF
PINK Zomedica Corp$0.0879 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0879, and at the day’s high of $0.0888
- YTD change
- -13.61%
- vs 20-day SMA
- +9.74%
- vs 200-day SMA
- -15.71%
Price ranges
Price & Performance
-0.02 (-20.81%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 44.4% away from all-time highs of $0.1580
- ZOMDF is down 14% since the beginning of the year
- ZOMDF is up 29% over the past 12 months
- ZOMDF is up 6% over the past 1 month
- 0% of all ZOMDF investors are betting against ZOMDF
ZOMDF reads very good: price sits above one of the two key moving averages, the 12-month move is +29.3%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0038
- Last 5 days
- +9.88%
- vs 8-day SMA
- +9.46%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Zomedica Corp. engages in the discovery, development, and commercialization of pharmaceuticals for companion animals, including dogs, cats, and horses. The firm offers products focusing on the unmet needs of clinical veterinarians. It operates through the following segments: Diagnostics, Therapeutic Devices, and Development Services. The Diagnostics segment offers TRUFORMA, VETGuardian and TRUVIEW products. The Therapeutic Devices segment consists of Assisi, PulseVet and VETIGEL products. The Development Services segment includes contract manufacturing and engineering services. The company was founded by Gerald L. Solensky on January 7, 2013 and is headquartered in Ann Arbor, MI.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
